Mavenclad “Now Approved” Page Apr 2, 2019Apr 3, 2019 Brand: Mavenclad (cladribine), Tablets Parent Company: EMD Serono Drug Type: Boxed Warning Drug Category: Neurology Campaign: now-approved Targeting: HCPs Patient Website: HCP Website: Homepage Homepage scroll Mobile